3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
9
Neoplasms
7
Anxiety Disorders
6
Depression
3
Ovarian Neoplasms
2
Chronic Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Tendinopathy
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sarcoma
1
Radiculopathy
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pathophobia
1
Pain, Postoperative
1
Pain
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Nausea
1
Myocarditis
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Lung Diseases, Interstitial
1
Leukemia, Myeloid, Acute
1
Hot Flashes
1
Interventions
Dexamethasone
4
Methods
2
Electroencephalography
2
selinexor
1
pomalidomide
1
ixazomib
1
Transurethral Resection of Bladder
1
Telemedicine
1
Tablets
1
Surgical Procedures, Operative
1
Standard of Care
1
Neurofeedback
1
Melphalan
1
Mass Screening
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hypnosis
1
Hormones
1
Exercise
1
Ethanol
1
Drug Delivery Systems
1
Cyclophosphamide
1
Control Groups
1
Cholinesterase Inhibitors
1
Calcium Dobesilate
1
Bortezomib
1
Biopsy
1
Amyloid
1
Amputation, Surgical
1
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Alzheimer Disease
×
Hypnosis
×
Clear all
NCT06116084
2023-11-03
HYDEM
Central Hospital, Nancy, France
Phase NA
Unknown
100 enrolled